Düring, Joachim
Annborn, Martin
Cariou, Alain
Chew, Michelle S.
Dankiewicz, Josef
Friberg, Hans
Haenggi, Matthias
Haxhija, Zana
Jakobsen, Janus C.
Langeland, Halvor
Taccone, Fabio Silvio
Thomas, Matthew
Ullén, Susann
Wise, Matt P.
Nielsen, Niklas
Funding for this research was provided by:
Lund University
Article History
Received: 21 March 2022
Accepted: 25 July 2022
First Online: 31 July 2022
Declarations
:
: The TTM trial protocol was approved by ethical committees in each participating country, and informed consent was waived or obtained from all participants or relatives according to national legislations, in line with the Helsinki declaration, Ethical Review Board approval, REPN Lund DNR 2015/228.
: Not applicable.
: JD: No financial or non-financial competing interests. MA: No financial or non-financial competing interests. AC: Received fees for lectures from Bard. MC: No financial or non-financial competing interests. JD: No financial or non-financial competing interests. HF: TEQCool (Lund, Sweden) Academic advisor. MH: No financial or non-financial competing interests. ZH: No financial or non-financial competing interests. JCJ: No financial or non-financial competing interests. HL: No financial or non-financial competing interests. FT: No financial or non-financial competing interests. MT: No financial competing interests, co-applicant on several NIHR cardiac arrest trials but not in the field of temperature management. SU: No financial or non-financial competing interests. MPW: No financial or non-financial competing interests. NN: No financial or non-financial competing interests.